Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We examined behaviour management problems as predictors of psychotropic medication, use of psychiatric consultation and in-patient admission in a group of 66 adults with pervasive developmental disorder (PDD) and intellectual disability (ID) and 99 controls matched in age, gender and level of ID. Overall, people with PDD had higher rates of most DAS behaviour problems and more frequent use of anti-psychotics than matched controls. Logistic regression analyses showed that physical aggression and problems such as pestering staff independently predicted use of anti-psychotics. Physical aggression and overactivity predicted further involvement of psychiatric services. PDD diagnosis predicted admission to an in-patient unit. The results suggest that externalizing problem behaviours in adults with autism can predict type of treatment intervention.
- Aman, M.G., Sarphare, G., & Burrow, W. H. (1995). Psychotropic drug use in group homes: prevalence and relation to demographic / psychiatric variables. American Journal on Mental Retardation, 99, 500–509.
- Billstedt, E., Gillberg, C., & Gillberg, C. (2005). Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. Journal of Autism and Developmental Disorders, 35, 351–360. CrossRef
- Bouras N. (eds), (1999). Psychiatric and behavioural disorders in developmental disabilities and mental retardation. Cambridge: Cambridge University Press.
- Carr, E. G., Horner, R., & Turnbull, A. P. (1999). Positive behaviour support in people with developmental disabilities: a research synthesis (Monograph (American Association on Mental Retardation). Washington, DC: American Association on Mental Retardation.
- Didden, R., Duker, P. C., & Korzilius, H. (1999). Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation. American Journal of Mental Retardation, 101, 387–399.
- Dinca, O., Paul, M., & Spencer, N. J. (2005). Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders. Journal of Psychopharmacology, 19, 521–532. CrossRef
- Fombonne, E. (1999). The epidemiology of autism: a review. Psychological Medicine, 29, 769–789. CrossRef
- Fombonne, E. (2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update. Journal of Autism and Developmental Disorders, 33, 365–382. CrossRef
- Grey, I. M., & Hastings, R. P. (2005). Evidence-based practices in intellectual disability and behaviour disorders. Current Opinion in Psychiatry, 18, 469–475. CrossRef
- Hanson, R. H., Weiseler, N. A., Lakin, C., & Braddock, D. L. (2002). Crisis prevention and response in the community. Washington, DC: AAMR.
- Howlin, P. (2003). Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and Asperger syndrome. Journal of Autism and Developmental Disorders, 33, 3–13. CrossRef
- Howlin, P. (1997). Autism: preparation for adulthood. London: Routledge.
- Kwok, H. W. M. (2003). Psychopharmacology in autism spectrum disorders. Current Opinion in Psychiatry, 16, 529–534. CrossRef
- McClintock, K., Hall, S., & Oliver, C. (2003). Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study. Journal of Intellectual Disability Research, 47, 405–416. CrossRef
- New York Department of Health (1999). Clinical practice guidelines: The guideline technical report. Autism / Pervasive Developmental Disorders. Assessment and inte4rvention for young children (age 0–3 year). Publication number 4217. Albany: New York Department of Health.
- Posey, D. J., & McDougle, C. J. (2000). The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harvard Review of Psychiatry, 8, 45–63. CrossRef
- Scotti, J. R., Evans, I. M., Meyer, L. H., & Walker, P. (1991). A meta-analysis of intervention research with problem behavior: treatment validity and standards of practice. American Journal on Mental Retardation, 96, 233–256.
- Singh, N. N., Ellis, C. R., & Wechsler, H. (1997). Psychopharmaco-epidemiology of mental retardation: 1966 to 1995. Journal of Child and Adolescent Psychopharmacology, 7, 255–266. CrossRef
- Sturmey, P., & Adams, C. (1999). Level of need and behavioral needs of persons admitted to institutions in Texas 1994 to 1998. Mental Retardation, 37, 497. CrossRef
- Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism
Journal of Autism and Developmental Disorders
Volume 37, Issue 6 , pp 1080-1085
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- Behaviour management problems
- Challenging behaviour
- Intellectual disability/ mental retardation
- Psychotropic medication
- Treatment interventions
- Industry Sectors
- Author Affiliations
- 1. Division of Psychological Medicine, Institute of Psychiatry, King’s College London, Estia Center, 66 Snowsfields, London, SE1 3SS, UK
- 2. Department of Psychology, Queens College, City University of New York, New York, NY, USA